High Dose Interferon Alpha 2b as Adjuvant Therapy in High-risk Resected Malignant Melanoma 10 Year Analysis of Patients Treated in Northern Ireland

Jain, S., Mulholland, L., McCourt, C., Connolly, D., Khan, F. , Wilson, J., Brady, D. and McAleer, S. (2007) High Dose Interferon Alpha 2b as Adjuvant Therapy in High-risk Resected Malignant Melanoma 10 Year Analysis of Patients Treated in Northern Ireland. NCRI Cancer Conference, Birmingham, UK, 30 Sep - 03 Oct 2007.

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Conference or Workshop Item
Additional Information:Poster no: A173.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Khan, Esfandiyar
Authors: Jain, S., Mulholland, L., McCourt, C., Connolly, D., Khan, F., Wilson, J., Brady, D., and McAleer, S.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing

University Staff: Request a correction | Enlighten Editors: Update this record